Standard BioTools switches Mass Cytometry sale to Element Biosystems for $5.5 million cash
Bitget2026/09/30 20:43- Standard BioTools replaced its prior Mass Cytometry divestiture deal with a definitive sale agreement to Element Biosystems.
- Element, an acquisition vehicle formed by GMT Venture Partners, will pay USD 5.5 million in cash at closing, subject to adjustments.
- The earlier agreement to sell the unit to Multiplex Bio was terminated after GMT Venture submitted an unsolicited proposal on Aug. 29, 2026.
- The revised terms lift net cash used in Treeline merger exchange-ratio calculations by about USD 15 million versus the Multiplex Bio deal.
- Closing is targeted by end-2026, substantially concurrent with the planned Treeline transaction, subject to stockholder approval and customary conditions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Citi: Besent May "Slash" Long-term Bond Issuance Next Month, 20-year US Treasury Issuance Could Be Directly Canceled
Citi published a research report indicating that US Treasury Secretary Scott Besant is highly likely to reduce the issuance size of long-term US Treasury bonds, and may even completely cancel the issuance of 20-year Treasury bonds.
Rising energy prices intensify inflation concerns; US Treasury yields increase again, with the 10-year rising to 5.25%.
Persistently high energy prices have intensified market concerns about the inflation outlook and reinforced investor expectations of further interest rate hikes by the Federal Reserve. After experiencing significant volatility earlier this week, U.S. Treasury yields are edging back toward recent highs.
Bastion Trading reports $78,263 SkyAI common share purchase
Bastion Trading, a 10% owner of SkyAI, bought 44,000 common shares at a weighted average price of $1.7787. Directly held common shares rose to 1,429,417 following the purchase. Indirect beneficial ownership disclosed at 2,940,075 common shares. Derivative exposure included 4,234,615 Pre-Funded Warrants, underlying common stock. Also held 5,384,615 Stapled Warrants, underlying common stock. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SkyAI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000921895-26-002775), on October 09, 2026, and is solely responsible for the information contained therein.
Crypto prices
More
